

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of cholesterol homeostasis (GO:2000188) | 5.06379428 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.71793866 |
| 3 | negative regulation of cell killing (GO:0031342) | 4.71793866 |
| 4 | serine family amino acid catabolic process (GO:0009071) | 4.57103504 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.47771211 |
| 6 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.47252103 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.43308277 |
| 8 | glycine metabolic process (GO:0006544) | 4.38870929 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.33298937 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 4.33298937 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.32980358 |
| 12 | urea cycle (GO:0000050) | 4.30220449 |
| 13 | urea metabolic process (GO:0019627) | 4.30220449 |
| 14 | cysteine metabolic process (GO:0006534) | 4.20579536 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 4.18875960 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 4.18875960 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 4.18875960 |
| 18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.18875960 |
| 19 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.18875960 |
| 20 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.18875960 |
| 21 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.16112522 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.14884677 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.13068038 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.11223115 |
| 25 | L-phenylalanine catabolic process (GO:0006559) | 4.10265398 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.10265398 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 4.07937853 |
| 28 | detection of other organism (GO:0098543) | 4.02319728 |
| 29 | kynurenine metabolic process (GO:0070189) | 3.99860855 |
| 30 | amino-acid betaine metabolic process (GO:0006577) | 3.94439787 |
| 31 | detection of bacterium (GO:0016045) | 3.93357995 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 3.88156441 |
| 33 | response to muramyl dipeptide (GO:0032495) | 3.82141442 |
| 34 | response to peptidoglycan (GO:0032494) | 3.81041285 |
| 35 | negative regulation of cholesterol transport (GO:0032375) | 3.77211441 |
| 36 | negative regulation of sterol transport (GO:0032372) | 3.77211441 |
| 37 | sulfur amino acid catabolic process (GO:0000098) | 3.75157880 |
| 38 | aromatic amino acid family catabolic process (GO:0009074) | 3.72941764 |
| 39 | regulation of protein activation cascade (GO:2000257) | 3.70671118 |
| 40 | negative regulation of fibrinolysis (GO:0051918) | 3.70084365 |
| 41 | leukocyte aggregation (GO:0070486) | 3.68096865 |
| 42 | lysine metabolic process (GO:0006553) | 3.67818120 |
| 43 | lysine catabolic process (GO:0006554) | 3.67818120 |
| 44 | complement activation, alternative pathway (GO:0006957) | 3.64995682 |
| 45 | tryptophan catabolic process (GO:0006569) | 3.60228636 |
| 46 | indole-containing compound catabolic process (GO:0042436) | 3.60228636 |
| 47 | indolalkylamine catabolic process (GO:0046218) | 3.60228636 |
| 48 | folic acid metabolic process (GO:0046655) | 3.57081106 |
| 49 | regulation of triglyceride catabolic process (GO:0010896) | 3.56954511 |
| 50 | serine family amino acid metabolic process (GO:0009069) | 3.56753255 |
| 51 | fructose metabolic process (GO:0006000) | 3.54727933 |
| 52 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.54686859 |
| 53 | regulation of complement activation (GO:0030449) | 3.51971610 |
| 54 | protein carboxylation (GO:0018214) | 3.50418214 |
| 55 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.50418214 |
| 56 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.49831328 |
| 57 | homocysteine metabolic process (GO:0050667) | 3.49446596 |
| 58 | positive thymic T cell selection (GO:0045059) | 3.48188057 |
| 59 | mannose metabolic process (GO:0006013) | 3.47183662 |
| 60 | phospholipid homeostasis (GO:0055091) | 3.46484358 |
| 61 | macrophage activation involved in immune response (GO:0002281) | 3.46204056 |
| 62 | bile acid biosynthetic process (GO:0006699) | 3.44247540 |
| 63 | tolerance induction (GO:0002507) | 3.40431569 |
| 64 | valine metabolic process (GO:0006573) | 3.40245429 |
| 65 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.40098175 |
| 66 | 2-oxoglutarate metabolic process (GO:0006103) | 3.39833060 |
| 67 | detection of external biotic stimulus (GO:0098581) | 3.39706248 |
| 68 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.38038516 |
| 69 | glyoxylate metabolic process (GO:0046487) | 3.36618850 |
| 70 | regulation of cholesterol storage (GO:0010885) | 3.34563472 |
| 71 | cellular extravasation (GO:0045123) | 3.33149961 |
| 72 | thymic T cell selection (GO:0045061) | 3.33015062 |
| 73 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.32840117 |
| 74 | tryptophan metabolic process (GO:0006568) | 3.30065432 |
| 75 | high-density lipoprotein particle remodeling (GO:0034375) | 3.29608032 |
| 76 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.29131097 |
| 77 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.27052116 |
| 78 | germinal center formation (GO:0002467) | 3.26275135 |
| 79 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.24092346 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 3.23789352 |
| 81 | neutrophil activation involved in immune response (GO:0002283) | 3.22019283 |
| 82 | phospholipid efflux (GO:0033700) | 3.18960838 |
| 83 | plasma lipoprotein particle clearance (GO:0034381) | 3.16598251 |
| 84 | low-density lipoprotein particle clearance (GO:0034383) | 3.16023379 |
| 85 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.15764643 |
| 86 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.15587446 |
| 87 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.13663515 |
| 88 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.13663515 |
| 89 | detection of molecule of bacterial origin (GO:0032490) | 3.13498193 |
| 90 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.13059294 |
| 91 | regulation of fibrinolysis (GO:0051917) | 3.10316157 |
| 92 | positive regulation of lipid catabolic process (GO:0050996) | 3.09963505 |
| 93 | response to laminar fluid shear stress (GO:0034616) | 3.09901652 |
| 94 | bile acid metabolic process (GO:0008206) | 3.07744679 |
| 95 | protein-lipid complex assembly (GO:0065005) | 3.07410750 |
| 96 | negative thymic T cell selection (GO:0045060) | 3.06252885 |
| 97 | fatty acid transmembrane transport (GO:1902001) | 3.05464988 |
| 98 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.03938380 |
| 99 | reverse cholesterol transport (GO:0043691) | 3.03892906 |
| 100 | alpha-amino acid catabolic process (GO:1901606) | 3.03400725 |
| 101 | T cell selection (GO:0045058) | 3.02809197 |
| 102 | serine family amino acid biosynthetic process (GO:0009070) | 3.02043163 |
| 103 | detection of biotic stimulus (GO:0009595) | 3.00610513 |
| 104 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.99167895 |
| 105 | regulation of translational termination (GO:0006449) | 2.99026584 |
| 106 | carnitine shuttle (GO:0006853) | 2.98049903 |
| 107 | positive T cell selection (GO:0043368) | 2.98042861 |
| 108 | response to interleukin-15 (GO:0070672) | 2.96902131 |
| 109 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.95906568 |
| 110 | neutrophil activation (GO:0042119) | 2.94541735 |
| 111 | negative T cell selection (GO:0043383) | 2.93373802 |
| 112 | triglyceride homeostasis (GO:0070328) | 2.92586986 |
| 113 | acylglycerol homeostasis (GO:0055090) | 2.92586986 |
| 114 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.92553031 |
| 115 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.92445043 |
| 116 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.91801872 |
| 117 | aromatic amino acid family metabolic process (GO:0009072) | 2.91666216 |
| 118 | negative regulation of lipid transport (GO:0032369) | 2.91384214 |
| 119 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.88809259 |
| 120 | positive regulation of lipid storage (GO:0010884) | 2.88725091 |
| 121 | regulation of bile acid biosynthetic process (GO:0070857) | 2.88111773 |
| 122 | cholesterol homeostasis (GO:0042632) | 2.88100726 |
| 123 | carnitine metabolic process (GO:0009437) | 2.87366163 |
| 124 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.86727001 |
| 125 | regulation of cholesterol esterification (GO:0010872) | 2.86486722 |
| 126 | NIK/NF-kappaB signaling (GO:0038061) | 2.85701418 |
| 127 | glutamate metabolic process (GO:0006536) | 2.85414645 |
| 128 | regulation of gamma-delta T cell activation (GO:0046643) | 2.84869976 |
| 129 | negative regulation of interleukin-12 production (GO:0032695) | 2.84761163 |
| 130 | regulation of leukocyte degranulation (GO:0043300) | 2.84473979 |
| 131 | sterol homeostasis (GO:0055092) | 2.82285488 |
| 132 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.82065839 |
| 133 | response to host (GO:0075136) | 2.82065839 |
| 134 | response to host defenses (GO:0052200) | 2.82065839 |
| 135 | granulocyte activation (GO:0036230) | 2.81803086 |
| 136 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.80180782 |
| 137 | histone H3-K36 demethylation (GO:0070544) | 2.79665375 |
| 138 | cellular amino acid catabolic process (GO:0009063) | 2.79190762 |
| 139 | fatty acid homeostasis (GO:0055089) | 2.77326379 |
| 140 | response to host immune response (GO:0052572) | 2.77305991 |
| 141 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.77305991 |
| 142 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.77014894 |
| 143 | macroautophagy (GO:0016236) | 2.76933908 |
| 144 | regulation of ARF protein signal transduction (GO:0032012) | 2.75663159 |
| 145 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.75289046 |
| 146 | regulation of triglyceride metabolic process (GO:0090207) | 2.75044869 |
| 147 | protein localization to endosome (GO:0036010) | 2.74180574 |
| 148 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.74128693 |
| 149 | negative regulation of interleukin-6 production (GO:0032715) | 2.73997126 |
| 150 | intestinal cholesterol absorption (GO:0030299) | 2.73415784 |
| 151 | protein-lipid complex remodeling (GO:0034368) | 2.72893547 |
| 152 | macromolecular complex remodeling (GO:0034367) | 2.72893547 |
| 153 | plasma lipoprotein particle remodeling (GO:0034369) | 2.72893547 |
| 154 | interferon-gamma secretion (GO:0072643) | 2.72709535 |
| 155 | cholesterol efflux (GO:0033344) | 2.71901736 |
| 156 | acetyl-CoA metabolic process (GO:0006084) | 2.70766005 |
| 157 | positive regulation of histone deacetylation (GO:0031065) | 2.68684822 |
| 158 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.68360553 |
| 159 | regulation of mast cell degranulation (GO:0043304) | 2.68338193 |
| 160 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.68258103 |
| 161 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.67427807 |
| 162 | carnitine transmembrane transport (GO:1902603) | 2.67419310 |
| 163 | ethanol oxidation (GO:0006069) | 2.65637763 |
| 164 | apoptotic process involved in morphogenesis (GO:0060561) | 2.65260014 |
| 165 | cellular modified amino acid catabolic process (GO:0042219) | 2.65256293 |
| 166 | negative regulation of innate immune response (GO:0045824) | 2.62811741 |
| 167 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.61572222 |
| 168 | embryonic process involved in female pregnancy (GO:0060136) | 2.60547564 |
| 169 | regulation of ARF GTPase activity (GO:0032312) | 2.58440091 |
| 170 | B cell receptor signaling pathway (GO:0050853) | 2.57755752 |
| 171 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.55646387 |
| 172 | positive regulation of protein deacetylation (GO:0090312) | 2.54687383 |
| 173 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.53728385 |
| 174 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.53299968 |
| 175 | signal complex assembly (GO:0007172) | 2.50502034 |
| 176 | respiratory burst (GO:0045730) | 2.49451168 |
| 177 | regulation of necroptotic process (GO:0060544) | 2.48976282 |
| 178 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.44671950 |
| 179 | response to type I interferon (GO:0034340) | 2.44269123 |
| 180 | positive regulation of Rap GTPase activity (GO:0032854) | 2.43537100 |
| 181 | macrophage activation (GO:0042116) | 2.43395421 |
| 182 | myeloid cell activation involved in immune response (GO:0002275) | 2.43131420 |
| 183 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.42810938 |
| 184 | cellular response to type I interferon (GO:0071357) | 2.42237750 |
| 185 | type I interferon signaling pathway (GO:0060337) | 2.42237750 |
| 186 | regulation of regulated secretory pathway (GO:1903305) | 2.41745672 |
| 187 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.39454251 |
| 188 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.39182230 |
| 189 | modulation by virus of host process (GO:0019054) | 2.39058777 |
| 190 | negative regulation of interleukin-8 production (GO:0032717) | 2.38671928 |
| 191 | modulation by symbiont of host cellular process (GO:0044068) | 2.38500505 |
| 192 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.36034998 |
| 193 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.34961754 |
| 194 | cellular response to interleukin-15 (GO:0071350) | 2.34530434 |
| 195 | negative regulation of T cell mediated immunity (GO:0002710) | 2.33713893 |
| 196 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.33265712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.23440601 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.91019054 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.83042581 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.02288837 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.72816177 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 2.55406189 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.54840585 |
| 8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.48105889 |
| 9 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.27594731 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.25459896 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.22664279 |
| 12 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.15956693 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.15804076 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.11913920 |
| 15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.02095902 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.99794994 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.99107743 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.95397881 |
| 19 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.94347533 |
| 20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.88536134 |
| 21 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76215968 |
| 22 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.73096849 |
| 23 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.70693916 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.69523079 |
| 25 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.68765765 |
| 26 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.68447388 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.68270560 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 1.64180021 |
| 29 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57381995 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55887706 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55874208 |
| 32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54896010 |
| 33 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.53198879 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.52132647 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.51400630 |
| 36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.51053994 |
| 37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.50407451 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.48695938 |
| 39 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.48693066 |
| 40 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46758835 |
| 41 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.45607778 |
| 42 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.42947509 |
| 43 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.42670424 |
| 44 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.41868598 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38614571 |
| 46 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.38505504 |
| 47 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.35403829 |
| 48 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.34783328 |
| 49 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34156216 |
| 50 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.33649410 |
| 51 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.33441760 |
| 52 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.33427927 |
| 53 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32897715 |
| 54 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32774343 |
| 55 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32658985 |
| 56 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.32657837 |
| 57 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32535017 |
| 58 | P68_20966046_ChIP-Seq_HELA_Human | 1.30059994 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29824406 |
| 60 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.29554646 |
| 61 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.26877729 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.24435738 |
| 63 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.24031904 |
| 64 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23968225 |
| 65 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23642075 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23497857 |
| 67 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.22983408 |
| 68 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.22869970 |
| 69 | MAF_26560356_Chip-Seq_TH2_Human | 1.18377178 |
| 70 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18362380 |
| 71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.18133811 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17534059 |
| 73 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.16465309 |
| 74 | MYB_26560356_Chip-Seq_TH1_Human | 1.15776246 |
| 75 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.14069573 |
| 76 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13890143 |
| 77 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.12807826 |
| 78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11888148 |
| 79 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.11668467 |
| 80 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11654089 |
| 81 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.10895844 |
| 82 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.08723843 |
| 83 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08670114 |
| 84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07176181 |
| 85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06513761 |
| 86 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06432022 |
| 87 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06038403 |
| 88 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05802733 |
| 89 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.05521112 |
| 90 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.05298075 |
| 91 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.04142531 |
| 92 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.02187981 |
| 93 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02183724 |
| 94 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.01463064 |
| 95 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01378189 |
| 96 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00822542 |
| 97 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.00269506 |
| 98 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99858471 |
| 99 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.99629371 |
| 100 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99536574 |
| 101 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.99415162 |
| 102 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98431272 |
| 103 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.98268231 |
| 104 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97808386 |
| 105 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97367934 |
| 106 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97239372 |
| 107 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97078751 |
| 108 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96397232 |
| 109 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.96259800 |
| 110 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95935055 |
| 111 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.94910146 |
| 112 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94860005 |
| 113 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94785216 |
| 114 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94619966 |
| 115 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.94215784 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94142157 |
| 117 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94131374 |
| 118 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.94107499 |
| 119 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.93824895 |
| 120 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.93768066 |
| 121 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93744505 |
| 122 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.93539933 |
| 123 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93262849 |
| 124 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.93236711 |
| 125 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.93062374 |
| 126 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.90923857 |
| 127 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.90851677 |
| 128 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89925908 |
| 129 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88829931 |
| 130 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88742881 |
| 131 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88348509 |
| 132 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.88311599 |
| 133 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87771921 |
| 134 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86964494 |
| 135 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.86683623 |
| 136 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85793956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.41591735 |
| 2 | MP0005360_urolithiasis | 4.34686807 |
| 3 | MP0009840_abnormal_foam_cell | 4.26945159 |
| 4 | MP0005365_abnormal_bile_salt | 3.74063445 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.52827930 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.02442291 |
| 7 | MP0008260_abnormal_autophagy | 2.99795450 |
| 8 | MP0003724_increased_susceptibility_to | 2.82128350 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.79666441 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.70762622 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.46764272 |
| 12 | MP0005670_abnormal_white_adipose | 2.46233019 |
| 13 | MP0003252_abnormal_bile_duct | 2.44712900 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.40759558 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.38132906 |
| 16 | MP0002419_abnormal_innate_immunity | 2.30145684 |
| 17 | MP0000609_abnormal_liver_physiology | 2.11566874 |
| 18 | MP0001835_abnormal_antigen_presentation | 2.06606111 |
| 19 | MP0004381_abnormal_hair_follicle | 2.06063802 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 2.03702706 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.03268909 |
| 22 | MP0002420_abnormal_adaptive_immunity | 1.84905740 |
| 23 | MP0001533_abnormal_skeleton_physiology | 1.83815183 |
| 24 | MP0001819_abnormal_immune_cell | 1.83014522 |
| 25 | MP0010352_gastrointestinal_tract_polyps | 1.79975654 |
| 26 | MP0005332_abnormal_amino_acid | 1.79414019 |
| 27 | MP0009278_abnormal_bone_marrow | 1.77373849 |
| 28 | MP0005083_abnormal_biliary_tract | 1.76549576 |
| 29 | MP0002254_reproductive_system_inflammat | 1.69137934 |
| 30 | MP0001666_abnormal_nutrient_absorption | 1.67280234 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.66116045 |
| 32 | MP0009785_altered_susceptibility_to | 1.60796787 |
| 33 | MP0002118_abnormal_lipid_homeostasis | 1.57828220 |
| 34 | MP0004019_abnormal_vitamin_homeostasis | 1.57506758 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.57266511 |
| 36 | MP0005671_abnormal_response_to | 1.56550988 |
| 37 | MP0008961_abnormal_basal_metabolism | 1.54323609 |
| 38 | MP0002405_respiratory_system_inflammati | 1.52393223 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.51544597 |
| 40 | MP0003828_pulmonary_edema | 1.51221351 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.51070877 |
| 42 | MP0004858_abnormal_nervous_system | 1.51036128 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.50608697 |
| 44 | MP0005076_abnormal_cell_differentiation | 1.46109923 |
| 45 | MP0000716_abnormal_immune_system | 1.44489134 |
| 46 | MP0004947_skin_inflammation | 1.43000336 |
| 47 | MP0003436_decreased_susceptibility_to | 1.42563063 |
| 48 | MP0002998_abnormal_bone_remodeling | 1.38905472 |
| 49 | MP0003111_abnormal_nucleus_morphology | 1.37098520 |
| 50 | MP0000858_altered_metastatic_potential | 1.35622867 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.32579170 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.32579170 |
| 53 | MP0002148_abnormal_hypersensitivity_rea | 1.29384355 |
| 54 | MP0003693_abnormal_embryo_hatching | 1.29257607 |
| 55 | MP0003866_abnormal_defecation | 1.28359499 |
| 56 | MP0003045_fibrosis | 1.28109980 |
| 57 | MP0003566_abnormal_cell_adhesion | 1.26650425 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.25598863 |
| 59 | MP0004130_abnormal_muscle_cell | 1.25134399 |
| 60 | MP0002132_abnormal_respiratory_system | 1.23522204 |
| 61 | MP0005310_abnormal_salivary_gland | 1.22874705 |
| 62 | MP0001851_eye_inflammation | 1.22358221 |
| 63 | MP0005451_abnormal_body_composition | 1.22289887 |
| 64 | MP0000598_abnormal_liver_morphology | 1.19915989 |
| 65 | MP0002429_abnormal_blood_cell | 1.18679058 |
| 66 | MP0005023_abnormal_wound_healing | 1.18334625 |
| 67 | MP0005409_darkened_coat_color | 1.17633787 |
| 68 | MP0004185_abnormal_adipocyte_glucose | 1.17234469 |
| 69 | MP0003303_peritoneal_inflammation | 1.16957411 |
| 70 | MP0000604_amyloidosis | 1.16105335 |
| 71 | MP0003091_abnormal_cell_migration | 1.14263526 |
| 72 | MP0006082_CNS_inflammation | 1.13906983 |
| 73 | MP0002933_joint_inflammation | 1.12399083 |
| 74 | MP0001853_heart_inflammation | 1.11773088 |
| 75 | MP0010307_abnormal_tumor_latency | 1.11287352 |
| 76 | MP0000678_abnormal_parathyroid_gland | 1.10455782 |
| 77 | MP0000685_abnormal_immune_system | 1.10107079 |
| 78 | MP0005464_abnormal_platelet_physiology | 1.09022867 |
| 79 | MP0009643_abnormal_urine_homeostasis | 1.08679739 |
| 80 | MP0004510_myositis | 1.07095216 |
| 81 | MP0002269_muscular_atrophy | 1.05249586 |
| 82 | MP0003075_altered_response_to | 1.04837086 |
| 83 | MP0004264_abnormal_extraembryonic_tissu | 1.02729889 |
| 84 | MP0005375_adipose_tissue_phenotype | 0.98771095 |
| 85 | MP0002009_preneoplasia | 0.97893623 |
| 86 | MP0001800_abnormal_humoral_immune | 0.96579050 |
| 87 | MP0003646_muscle_fatigue | 0.95211130 |
| 88 | MP0001764_abnormal_homeostasis | 0.95192638 |
| 89 | MP0003195_calcinosis | 0.93490617 |
| 90 | MP0001348_abnormal_lacrimal_gland | 0.92655751 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 0.91895562 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.90660251 |
| 93 | MP0005058_abnormal_lysosome_morphology | 0.89376301 |
| 94 | MP0003329_amyloid_beta_deposits | 0.88155702 |
| 95 | MP0002877_abnormal_melanocyte_morpholog | 0.87189267 |
| 96 | MP0008469_abnormal_protein_level | 0.86811924 |
| 97 | MP0002796_impaired_skin_barrier | 0.86673755 |
| 98 | MP0010630_abnormal_cardiac_muscle | 0.85210163 |
| 99 | MP0005390_skeleton_phenotype | 0.84218615 |
| 100 | MP0001849_ear_inflammation | 0.83979511 |
| 101 | MP0003763_abnormal_thymus_physiology | 0.82896970 |
| 102 | MP0009931_abnormal_skin_appearance | 0.82407786 |
| 103 | MP0003183_abnormal_peptide_metabolism | 0.82086472 |
| 104 | MP0000689_abnormal_spleen_morphology | 0.81936063 |
| 105 | MP0001730_embryonic_growth_arrest | 0.81583922 |
| 106 | MP0002971_abnormal_brown_adipose | 0.81392804 |
| 107 | MP0009763_increased_sensitivity_to | 0.80222206 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.79553190 |
| 109 | MP0002722_abnormal_immune_system | 0.79426474 |
| 110 | MP0005166_decreased_susceptibility_to | 0.78023632 |
| 111 | MP0005334_abnormal_fat_pad | 0.77973603 |
| 112 | MP0005501_abnormal_skin_physiology | 0.77819129 |
| 113 | MP0002088_abnormal_embryonic_growth/wei | 0.77716825 |
| 114 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77556853 |
| 115 | MP0003984_embryonic_growth_retardation | 0.76592340 |
| 116 | MP0009764_decreased_sensitivity_to | 0.76201594 |
| 117 | MP0004883_abnormal_blood_vessel | 0.75857907 |
| 118 | MP0009115_abnormal_fat_cell | 0.75675907 |
| 119 | MP0005387_immune_system_phenotype | 0.74713165 |
| 120 | MP0001790_abnormal_immune_system | 0.74713165 |
| 121 | MP0004808_abnormal_hematopoietic_stem | 0.74589744 |
| 122 | MP0002332_abnormal_exercise_endurance | 0.74283309 |
| 123 | MP0002086_abnormal_extraembryonic_tissu | 0.74180692 |
| 124 | MP0002970_abnormal_white_adipose | 0.73667524 |
| 125 | MP0002006_tumorigenesis | 0.73433495 |
| 126 | MP0005380_embryogenesis_phenotype | 0.72883589 |
| 127 | MP0001672_abnormal_embryogenesis/_devel | 0.72883589 |
| 128 | MP0009672_abnormal_birth_weight | 0.72287756 |
| 129 | MP0001756_abnormal_urination | 0.72225114 |
| 130 | MP0005164_abnormal_response_to | 0.72075289 |
| 131 | MP0002398_abnormal_bone_marrow | 0.71847543 |
| 132 | MP0008004_abnormal_stomach_pH | 0.71689105 |
| 133 | MP0000249_abnormal_blood_vessel | 0.70813496 |
| 134 | MP0001845_abnormal_inflammatory_respons | 0.69974084 |
| 135 | MP0002396_abnormal_hematopoietic_system | 0.69704980 |
| 136 | MP0005377_hearing/vestibular/ear_phenot | 0.69179186 |
| 137 | MP0003878_abnormal_ear_physiology | 0.69179186 |
| 138 | MP0001873_stomach_inflammation | 0.69167355 |
| 139 | MP0010155_abnormal_intestine_physiology | 0.67745107 |
| 140 | MP0002723_abnormal_immune_serum | 0.67500753 |
| 141 | MP0010234_abnormal_vibrissa_follicle | 0.66540959 |
| 142 | MP0000371_diluted_coat_color | 0.63756735 |
| 143 | MP0004084_abnormal_cardiac_muscle | 0.63465283 |
| 144 | MP0003077_abnormal_cell_cycle | 0.63244294 |
| 145 | MP0005025_abnormal_response_to | 0.63242656 |
| 146 | MP0000703_abnormal_thymus_morphology | 0.63037581 |
| 147 | MP0002452_abnormal_antigen_presenting | 0.62850918 |
| 148 | MP0002060_abnormal_skin_morphology | 0.62463794 |
| 149 | MP0004087_abnormal_muscle_fiber | 0.62207376 |
| 150 | MP0009642_abnormal_blood_homeostasis | 0.61549514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.19708160 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.65649577 |
| 3 | Xanthomatosis (HP:0000991) | 4.38341044 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.02577301 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 3.99970353 |
| 6 | Hyperglycinuria (HP:0003108) | 3.88429292 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.67069450 |
| 8 | Myositis (HP:0100614) | 3.64597334 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.63239545 |
| 10 | Myocardial infarction (HP:0001658) | 3.60561410 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.52024035 |
| 12 | Complement deficiency (HP:0004431) | 3.50037287 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 3.48111973 |
| 14 | Hyperglycinemia (HP:0002154) | 3.47197814 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.46686515 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 3.43784062 |
| 17 | Orchitis (HP:0100796) | 3.40805717 |
| 18 | Hypoalphalipoproteinemia (HP:0003233) | 3.37748633 |
| 19 | Obstructive sleep apnea (HP:0002870) | 3.36234743 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.31878500 |
| 21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.28165736 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 3.28165736 |
| 23 | Hypolipoproteinemia (HP:0010981) | 3.20060663 |
| 24 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.10911491 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 3.07527407 |
| 26 | Polycythemia (HP:0001901) | 3.05831596 |
| 27 | Hyperammonemia (HP:0001987) | 3.05239854 |
| 28 | Optic neuritis (HP:0100653) | 2.96066545 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 2.96066545 |
| 30 | Hypercholesterolemia (HP:0003124) | 2.95910786 |
| 31 | Stomatitis (HP:0010280) | 2.81630999 |
| 32 | Epidermoid cyst (HP:0200040) | 2.81087199 |
| 33 | Abnormality of complement system (HP:0005339) | 2.79841376 |
| 34 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.78445017 |
| 35 | Prolonged partial thromboplastin time (HP:0003645) | 2.75612272 |
| 36 | Recurrent fungal infections (HP:0002841) | 2.73010780 |
| 37 | Gingivitis (HP:0000230) | 2.72839817 |
| 38 | Broad face (HP:0000283) | 2.70039824 |
| 39 | Pustule (HP:0200039) | 2.65848477 |
| 40 | Cellulitis (HP:0100658) | 2.63061410 |
| 41 | Obstructive lung disease (HP:0006536) | 2.61245168 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.61245168 |
| 43 | Abnormality of the common coagulation pathway (HP:0010990) | 2.58865035 |
| 44 | Ketosis (HP:0001946) | 2.55776262 |
| 45 | Joint hemorrhage (HP:0005261) | 2.54285006 |
| 46 | Esophageal varix (HP:0002040) | 2.53636197 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 2.52450601 |
| 48 | Atrioventricular block (HP:0001678) | 2.52244372 |
| 49 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51625025 |
| 50 | Global brain atrophy (HP:0002283) | 2.50596358 |
| 51 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.49148045 |
| 52 | Abnormality of the lower motor neuron (HP:0002366) | 2.46289569 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.46247560 |
| 54 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.45191742 |
| 55 | Meningitis (HP:0001287) | 2.42863356 |
| 56 | Gastrointestinal inflammation (HP:0004386) | 2.42496283 |
| 57 | Reticulocytosis (HP:0001923) | 2.40693513 |
| 58 | Recurrent skin infections (HP:0001581) | 2.37868615 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.35570934 |
| 60 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.35311422 |
| 61 | Gout (HP:0001997) | 2.34603238 |
| 62 | Poikilocytosis (HP:0004447) | 2.34209470 |
| 63 | Abnormality of methionine metabolism (HP:0010901) | 2.31941155 |
| 64 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.30873990 |
| 65 | Hypochromic anemia (HP:0001931) | 2.28954223 |
| 66 | Alopecia of scalp (HP:0002293) | 2.28602182 |
| 67 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.28073946 |
| 68 | Bundle branch block (HP:0011710) | 2.26971153 |
| 69 | Slow saccadic eye movements (HP:0000514) | 2.26663013 |
| 70 | Difficulty climbing stairs (HP:0003551) | 2.23046236 |
| 71 | Inflammation of the large intestine (HP:0002037) | 2.22676738 |
| 72 | Autoimmune thrombocytopenia (HP:0001973) | 2.22005337 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.20479183 |
| 74 | Chest pain (HP:0100749) | 2.18188275 |
| 75 | Skin nodule (HP:0200036) | 2.17821903 |
| 76 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.16261081 |
| 77 | Hypoglycemic coma (HP:0001325) | 2.16085109 |
| 78 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.15374284 |
| 79 | Vasculitis (HP:0002633) | 2.15283037 |
| 80 | Increased connective tissue (HP:0009025) | 2.15247498 |
| 81 | Cerebral aneurysm (HP:0004944) | 2.15164004 |
| 82 | Abnormality of nucleobase metabolism (HP:0010932) | 2.11378859 |
| 83 | Urticaria (HP:0001025) | 2.09147913 |
| 84 | Systemic lupus erythematosus (HP:0002725) | 2.07415433 |
| 85 | Epistaxis (HP:0000421) | 2.06903642 |
| 86 | Distal upper limb amyotrophy (HP:0007149) | 2.06837409 |
| 87 | Upper limb amyotrophy (HP:0009129) | 2.06837409 |
| 88 | Hyperglycemia (HP:0003074) | 2.06753691 |
| 89 | Dysmetric saccades (HP:0000641) | 2.06470065 |
| 90 | Distal lower limb amyotrophy (HP:0008944) | 2.06272880 |
| 91 | Gingival bleeding (HP:0000225) | 2.06015991 |
| 92 | Upper motor neuron abnormality (HP:0002127) | 2.05938460 |
| 93 | Dysostosis multiplex (HP:0000943) | 2.05904216 |
| 94 | Recurrent cutaneous fungal infections (HP:0011370) | 2.05341545 |
| 95 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.05341545 |
| 96 | Nasal polyposis (HP:0100582) | 2.04868508 |
| 97 | Hemorrhage of the eye (HP:0011885) | 2.02434827 |
| 98 | Spastic diplegia (HP:0001264) | 2.01603785 |
| 99 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.01249277 |
| 100 | Interstitial pulmonary disease (HP:0006530) | 2.00728283 |
| 101 | Abnormality of the Achilles tendon (HP:0005109) | 2.00223102 |
| 102 | Hand muscle atrophy (HP:0009130) | 1.99711905 |
| 103 | Increased cerebral lipofuscin (HP:0011813) | 1.99353557 |
| 104 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98788774 |
| 105 | Acanthocytosis (HP:0001927) | 1.98326702 |
| 106 | Episodic fever (HP:0001954) | 1.97154056 |
| 107 | Abnormality of the fingertips (HP:0001211) | 1.96845174 |
| 108 | Abnormality of the nasal mucosa (HP:0000433) | 1.95883152 |
| 109 | Amyloidosis (HP:0011034) | 1.95755984 |
| 110 | Abnormality of purine metabolism (HP:0004352) | 1.94472417 |
| 111 | Easy fatigability (HP:0003388) | 1.94298898 |
| 112 | Keratoconjunctivitis (HP:0001096) | 1.93982523 |
| 113 | Recurrent viral infections (HP:0004429) | 1.93718760 |
| 114 | Hypochromic microcytic anemia (HP:0004840) | 1.92891988 |
| 115 | Thin bony cortex (HP:0002753) | 1.92854367 |
| 116 | Encephalitis (HP:0002383) | 1.92533029 |
| 117 | Onion bulb formation (HP:0003383) | 1.92293687 |
| 118 | Metaphyseal cupping (HP:0003021) | 1.91600190 |
| 119 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.91567604 |
| 120 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.91567604 |
| 121 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.91567604 |
| 122 | Hypertriglyceridemia (HP:0002155) | 1.91036813 |
| 123 | Subacute progressive viral hepatitis (HP:0006572) | 1.90889856 |
| 124 | Abnormality of serum amino acid levels (HP:0003112) | 1.90528597 |
| 125 | Arterial thrombosis (HP:0004420) | 1.89156022 |
| 126 | Fat malabsorption (HP:0002630) | 1.88906549 |
| 127 | Heterotopia (HP:0002282) | 1.87831622 |
| 128 | Peritonitis (HP:0002586) | 1.85683375 |
| 129 | Disproportionate tall stature (HP:0001519) | 1.85551715 |
| 130 | Heart block (HP:0012722) | 1.84650860 |
| 131 | Stridor (HP:0010307) | 1.83053923 |
| 132 | Flat acetabular roof (HP:0003180) | 1.82588250 |
| 133 | Aneurysm (HP:0002617) | 1.82242113 |
| 134 | Increased variability in muscle fiber diameter (HP:0003557) | 1.81583050 |
| 135 | Right ventricular cardiomyopathy (HP:0011663) | 1.80751964 |
| 136 | Malnutrition (HP:0004395) | 1.80742661 |
| 137 | Hyperbilirubinemia (HP:0002904) | 1.80634646 |
| 138 | Mitral stenosis (HP:0001718) | 1.79301018 |
| 139 | Mucopolysacchariduria (HP:0008155) | 1.78057233 |
| 140 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.78057233 |
| 141 | Impulsivity (HP:0100710) | 1.77771480 |
| 142 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.77750742 |
| 143 | Polygenic inheritance (HP:0010982) | 1.77458979 |
| 144 | Dislocated radial head (HP:0003083) | 1.77424514 |
| 145 | Neonatal death (HP:0003811) | 1.77333152 |
| 146 | Abnormal atrioventricular conduction (HP:0005150) | 1.76989998 |
| 147 | Multiple enchondromatosis (HP:0005701) | 1.76910014 |
| 148 | Abnormality of the thoracic spine (HP:0100711) | 1.76760502 |
| 149 | Abnormality of iron homeostasis (HP:0011031) | 1.76480394 |
| 150 | Testicular atrophy (HP:0000029) | 1.76241032 |
| 151 | Cholelithiasis (HP:0001081) | 1.75899773 |
| 152 | Colitis (HP:0002583) | 1.75700549 |
| 153 | Pseudobulbar signs (HP:0002200) | 1.75483179 |
| 154 | Pulmonary infiltrates (HP:0002113) | 1.74861756 |
| 155 | Papilloma (HP:0012740) | 1.74422138 |
| 156 | Verrucae (HP:0200043) | 1.74422138 |
| 157 | Hemoptysis (HP:0002105) | 1.73977411 |
| 158 | Dicarboxylic aciduria (HP:0003215) | 1.73946140 |
| 159 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.73946140 |
| 160 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.73449476 |
| 161 | Axonal loss (HP:0003447) | 1.73178339 |
| 162 | Vascular calcification (HP:0004934) | 1.73046723 |
| 163 | Long palpebral fissure (HP:0000637) | 1.72403304 |
| 164 | Sensorimotor neuropathy (HP:0007141) | 1.72269767 |
| 165 | Stroke (HP:0001297) | 1.71939940 |
| 166 | Difficulty running (HP:0009046) | 1.71831450 |
| 167 | Hepatocellular carcinoma (HP:0001402) | 1.71368259 |
| 168 | Acne (HP:0001061) | 1.70361220 |
| 169 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.70330457 |
| 170 | Abnormality of the intrinsic pathway (HP:0010989) | 1.69836122 |
| 171 | Loss of speech (HP:0002371) | 1.69834336 |
| 172 | Spontaneous abortion (HP:0005268) | 1.68022979 |
| 173 | Increased serum ferritin (HP:0003281) | 1.67875658 |
| 174 | Osteomyelitis (HP:0002754) | 1.67267168 |
| 175 | Emphysema (HP:0002097) | 1.66913354 |
| 176 | Anorexia (HP:0002039) | 1.66809290 |
| 177 | Abnormal platelet volume (HP:0011876) | 1.65281284 |
| 178 | Tetraplegia (HP:0002445) | 1.64563883 |
| 179 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.64349440 |
| 180 | Status epilepticus (HP:0002133) | 1.63351482 |
| 181 | Increased IgE level (HP:0003212) | 1.63197848 |
| 182 | J-shaped sella turcica (HP:0002680) | 1.62544026 |
| 183 | Abnormality of the radial head (HP:0003995) | 1.62525058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.03746906 |
| 2 | PRPF4B | 3.52235505 |
| 3 | CDK12 | 3.32292709 |
| 4 | ERN1 | 3.17078667 |
| 5 | MAP4K1 | 2.87648510 |
| 6 | FGFR4 | 2.68571312 |
| 7 | IRAK3 | 2.68127244 |
| 8 | SMG1 | 2.63644269 |
| 9 | RIPK4 | 2.54364157 |
| 10 | PKN2 | 2.50874190 |
| 11 | MAP3K10 | 2.43787152 |
| 12 | EEF2K | 2.35169667 |
| 13 | BCKDK | 2.13644067 |
| 14 | EPHA2 | 2.10642538 |
| 15 | TNK2 | 1.96517732 |
| 16 | SIK1 | 1.96114414 |
| 17 | ICK | 1.82951512 |
| 18 | TTN | 1.79525850 |
| 19 | MARK2 | 1.70648568 |
| 20 | TAOK1 | 1.65687760 |
| 21 | RIPK1 | 1.60845191 |
| 22 | GRK6 | 1.60354068 |
| 23 | NEK2 | 1.53981449 |
| 24 | TYK2 | 1.53729428 |
| 25 | BLK | 1.50255524 |
| 26 | PTK6 | 1.48673117 |
| 27 | PRKD2 | 1.48284188 |
| 28 | MTOR | 1.44106422 |
| 29 | SIK3 | 1.36416050 |
| 30 | STK10 | 1.31520138 |
| 31 | EPHB1 | 1.30465233 |
| 32 | ZAP70 | 1.27105578 |
| 33 | TAOK2 | 1.25468177 |
| 34 | FES | 1.24340113 |
| 35 | CAMK1D | 1.22837206 |
| 36 | PDK4 | 1.22072117 |
| 37 | PDK3 | 1.22072117 |
| 38 | CDK4 | 1.20618087 |
| 39 | IRAK2 | 1.20390659 |
| 40 | MAP3K13 | 1.19897516 |
| 41 | ALK | 1.19038361 |
| 42 | MAP2K3 | 1.17364215 |
| 43 | JAK3 | 1.16281073 |
| 44 | KSR2 | 1.15143609 |
| 45 | MAP3K14 | 1.13649717 |
| 46 | BUB1 | 1.12994171 |
| 47 | JAK1 | 1.08173342 |
| 48 | TAOK3 | 1.07702463 |
| 49 | MAP3K11 | 1.04458027 |
| 50 | CDC42BPA | 1.04045426 |
| 51 | IRAK1 | 1.02008649 |
| 52 | MAP3K3 | 0.98817519 |
| 53 | HIPK2 | 0.98673738 |
| 54 | PIM1 | 0.97683755 |
| 55 | TBK1 | 0.96166426 |
| 56 | TTK | 0.94311342 |
| 57 | FGFR3 | 0.93770637 |
| 58 | STK38 | 0.93029156 |
| 59 | BMX | 0.89623940 |
| 60 | SGK3 | 0.88808938 |
| 61 | MAP3K7 | 0.87668525 |
| 62 | CAMK1G | 0.86129941 |
| 63 | LATS1 | 0.85737396 |
| 64 | MAPK11 | 0.84167028 |
| 65 | MAP3K6 | 0.82631200 |
| 66 | CHUK | 0.80968400 |
| 67 | JAK2 | 0.80219607 |
| 68 | PNCK | 0.79736566 |
| 69 | PTK2 | 0.79316931 |
| 70 | MAP3K8 | 0.79149151 |
| 71 | STK4 | 0.75632638 |
| 72 | TXK | 0.74789018 |
| 73 | LRRK2 | 0.74327275 |
| 74 | RPS6KA4 | 0.72728698 |
| 75 | RPS6KL1 | 0.72202600 |
| 76 | RPS6KC1 | 0.72202600 |
| 77 | RPS6KA2 | 0.72012467 |
| 78 | SIK2 | 0.70401014 |
| 79 | TYRO3 | 0.69697130 |
| 80 | TESK2 | 0.69438725 |
| 81 | PDK2 | 0.68658610 |
| 82 | PAK4 | 0.68566715 |
| 83 | IKBKB | 0.68322354 |
| 84 | CDK6 | 0.66697600 |
| 85 | HCK | 0.65664552 |
| 86 | CAMKK1 | 0.65102067 |
| 87 | NEK1 | 0.64617283 |
| 88 | MARK3 | 0.64359618 |
| 89 | MAP2K2 | 0.63312140 |
| 90 | SYK | 0.62632160 |
| 91 | BRD4 | 0.61921592 |
| 92 | RPS6KB2 | 0.61556960 |
| 93 | FGR | 0.61062112 |
| 94 | LCK | 0.60852523 |
| 95 | PRKAA1 | 0.60590345 |
| 96 | STK3 | 0.60518127 |
| 97 | MAP3K9 | 0.59111547 |
| 98 | RPS6KA6 | 0.57742133 |
| 99 | NLK | 0.56043990 |
| 100 | WEE1 | 0.54775305 |
| 101 | RET | 0.54677838 |
| 102 | PDGFRA | 0.53815326 |
| 103 | PDPK1 | 0.53457590 |
| 104 | PDK1 | 0.53344238 |
| 105 | IKBKE | 0.53082222 |
| 106 | ZAK | 0.52627939 |
| 107 | CSF1R | 0.52426164 |
| 108 | FLT3 | 0.50801288 |
| 109 | MAP3K2 | 0.49848709 |
| 110 | LYN | 0.48645340 |
| 111 | PLK4 | 0.47921828 |
| 112 | CSK | 0.47610597 |
| 113 | TGFBR2 | 0.47306947 |
| 114 | RPS6KA1 | 0.46497269 |
| 115 | ITK | 0.45553653 |
| 116 | PRKD3 | 0.45095003 |
| 117 | KDR | 0.44836005 |
| 118 | DYRK3 | 0.44440463 |
| 119 | MST1R | 0.44241312 |
| 120 | MAP3K1 | 0.43389703 |
| 121 | MELK | 0.43278713 |
| 122 | LATS2 | 0.42575981 |
| 123 | DYRK1B | 0.42125220 |
| 124 | MAP2K6 | 0.40846222 |
| 125 | MAPK7 | 0.40324250 |
| 126 | PRKAA2 | 0.40138878 |
| 127 | MAPK12 | 0.39268166 |
| 128 | CAMK4 | 0.38261465 |
| 129 | PRKG2 | 0.37399578 |
| 130 | BTK | 0.37125788 |
| 131 | MAPKAPK2 | 0.36214187 |
| 132 | CHEK1 | 0.35079629 |
| 133 | PRKCH | 0.33726569 |
| 134 | IRAK4 | 0.33521336 |
| 135 | PINK1 | 0.33494299 |
| 136 | STK11 | 0.33137065 |
| 137 | PDGFRB | 0.32651512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.53453078 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.44239917 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.42979654 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.89360595 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.51211467 |
| 6 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.36442268 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.34339266 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.25779181 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.21185657 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.13903716 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.08893235 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 2.06993372 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.96922161 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.94201098 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.87339813 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.86701272 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.77525433 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.73770890 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.72392106 |
| 20 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.70400984 |
| 21 | Lysine degradation_Homo sapiens_hsa00310 | 1.70209120 |
| 22 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.63995373 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.63917963 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.57705898 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.57624912 |
| 26 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52495497 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.52100722 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.51637932 |
| 29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.45261569 |
| 30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.43265062 |
| 31 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.43264314 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.40613666 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40321163 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.39016123 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.38894449 |
| 36 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.38431232 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.38078526 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.37410726 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 1.35648955 |
| 40 | Sulfur relay system_Homo sapiens_hsa04122 | 1.35251933 |
| 41 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.35226340 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.34654781 |
| 43 | Bile secretion_Homo sapiens_hsa04976 | 1.31995996 |
| 44 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.31452411 |
| 45 | Endometrial cancer_Homo sapiens_hsa05213 | 1.30259622 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.30016539 |
| 47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.27979955 |
| 48 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.26426826 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.26262779 |
| 50 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.25219256 |
| 51 | Hepatitis B_Homo sapiens_hsa05161 | 1.24254576 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 1.23801231 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.23337563 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 1.23211277 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21207922 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.19054069 |
| 57 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18917184 |
| 58 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.16247536 |
| 59 | Malaria_Homo sapiens_hsa05144 | 1.14586621 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12314991 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.10545694 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.10273901 |
| 63 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.10199154 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10134097 |
| 65 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.09682279 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08986366 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.08457953 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 1.07780723 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.07773341 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.07364124 |
| 71 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.03678952 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 1.01982034 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.01652376 |
| 74 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01256351 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.01021286 |
| 76 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.99891088 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.99473101 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.98706818 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98697940 |
| 80 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96166510 |
| 81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94699423 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.94619109 |
| 83 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93989777 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93703299 |
| 85 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93607997 |
| 86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92960835 |
| 87 | Retinol metabolism_Homo sapiens_hsa00830 | 0.91634878 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.90822416 |
| 89 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88867008 |
| 90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83711757 |
| 91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82934719 |
| 92 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82596698 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.82542483 |
| 94 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81849819 |
| 95 | Prostate cancer_Homo sapiens_hsa05215 | 0.80468550 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.80074660 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79304133 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.78919265 |
| 99 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.78229195 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77322885 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77259768 |
| 102 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.75348181 |
| 103 | Legionellosis_Homo sapiens_hsa05134 | 0.74896004 |
| 104 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.74827067 |
| 105 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.74252744 |
| 106 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73545437 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.73044774 |
| 108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.72857371 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72589980 |
| 110 | Pertussis_Homo sapiens_hsa05133 | 0.72277595 |
| 111 | Allograft rejection_Homo sapiens_hsa05330 | 0.71557261 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71449221 |
| 113 | Salmonella infection_Homo sapiens_hsa05132 | 0.71375960 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70238144 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.69990778 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.69845721 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69473196 |
| 118 | Shigellosis_Homo sapiens_hsa05131 | 0.67467545 |
| 119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67329149 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65548583 |
| 121 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65055221 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.64839824 |
| 123 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63761545 |
| 124 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63009519 |
| 125 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60878280 |
| 126 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.60603091 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60468278 |
| 128 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60256877 |
| 129 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60225048 |
| 130 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.59708729 |
| 131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58153672 |
| 132 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55173202 |
| 133 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54525849 |
| 134 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53813332 |
| 135 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.53040546 |
| 136 | Long-term potentiation_Homo sapiens_hsa04720 | 0.51140889 |
| 137 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50468177 |
| 138 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49817827 |
| 139 | Focal adhesion_Homo sapiens_hsa04510 | 0.49730525 |
| 140 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44037948 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42540950 |
| 142 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41018772 |
| 143 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.39506664 |
| 144 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39070006 |
| 145 | Apoptosis_Homo sapiens_hsa04210 | 0.38541816 |
| 146 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.38441067 |
| 147 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38423665 |
| 148 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37842834 |
| 149 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37830409 |
| 150 | Prion diseases_Homo sapiens_hsa05020 | 0.37361513 |
| 151 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34682866 |
| 152 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34329335 |
| 153 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32191605 |
| 154 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.28650128 |
| 155 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.27986633 |
| 156 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.27888158 |
| 157 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.26794559 |
| 158 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.26733481 |
| 159 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.26144678 |
| 160 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24744462 |
| 161 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.24524136 |
| 162 | RNA transport_Homo sapiens_hsa03013 | 0.24241895 |
| 163 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.23851432 |
| 164 | Leishmaniasis_Homo sapiens_hsa05140 | 0.23607980 |
| 165 | Influenza A_Homo sapiens_hsa05164 | 0.23020945 |
| 166 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.22548771 |
| 167 | Measles_Homo sapiens_hsa05162 | 0.21894141 |

